Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.60 |
| ▸ | LPAR1 | Q92633 | 9/20 | 0.59 |
| ▸ | LPAR3 | Q9UBY5 | 9/20 | 0.59 |
| ▸ | LPAR2 | Q9HBW0 | 4/20 | 0.59 |
| ▸ | LPAR6 | P43657 | 3/20 | 0.59 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.59 |
| ▸ | LPAR5 | Q9H1C0 | 3/20 | 0.59 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.56 |
| ▸ | PRKCG | P05129 | 1/20 | 0.56 |
| ▸ | PRKCB | P05771 | 1/20 | 0.56 |
| ▸ | PRKCA | P17252 | 1/20 | 0.56 |
| ▸ | PRKCH | P24723 | 1/20 | 0.56 |
| ▸ | PRKCI | P41743 | 1/20 | 0.56 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.56 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.56 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.56 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.56 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19668143 | 1.00 | USP2 (0.60) | USP2LPAR1LPAR3LPAR2LPAR6 | |
| SCHEMBL5796672 | 0.98 | USP2 (0.63) | USP2LPAR1LPAR3LPAR2LPAR6 | |
| SCHEMBL10949767 | 0.98 | USP2 (0.63) | USP2LPAR1LPAR3LPAR2LPAR6 | |
| SCHEMBL2671655 | 0.98 | USP2 (0.63) | USP2LPAR1LPAR3LPAR2LPAR6 | |
| SCHEMBL10204069 | 0.98 | USP2 (0.63) | USP2LPAR1LPAR3LPAR2LPAR6 | |
| SCHEMBL10959285 | 0.98 | USP2 (0.63) | USP2LPAR1LPAR3LPAR2LPAR6 | |
| SCHEMBL10549855 | 0.98 | USP2 (0.63) | USP2LPAR1LPAR3LPAR2LPAR6 | |
| SCHEMBL10566104 | 0.98 | USP2 (0.63) | USP2LPAR1LPAR3LPAR2LPAR6 | |
| SCHEMBL133766 | 0.98 | USP2 (0.63) | USP2LPAR1LPAR3LPAR2LPAR6 | |
| SCHEMBL10565936 | 0.98 | USP2 (0.63) | USP2LPAR1LPAR3LPAR2LPAR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3630057-B1 | PERFUMES IN THE FORM OF AQUEOUS MICROEMULSIONS | CHANEL PARFUMS BEAUTE (FR) | 2021-08-18 | — | — | EP | disclosed |
| EP-3630057-B1 | PERFUMES IN THE FORM OF AQUEOUS MICROEMULSIONS | CHANEL PARFUMS BEAUTE (FR) | 2021-08-18 | — | — | EP | disclosed |
| US-11052025-B2 | Perfumes in the form of aqueous microemulsions | CHANEL PARFUMS BEAUTE (FR) | 2021-07-06 | — | — | US | disclosed |
| US-11052025-B2 | Perfumes in the form of aqueous microemulsions | CHANEL PARFUMS BEAUTE (FR) | 2021-07-06 | — | — | US | disclosed |
| US-20200323749-A1 | PERFUMES IN THE FORM OF AQUEOUS MICROEMULSIONS | CHANEL PARFUMS BEAUTE (FR) | 2020-10-15 | — | — | US | disclosed |
| US-20200323749-A1 | PERFUMES IN THE FORM OF AQUEOUS MICROEMULSIONS | CHANEL PARFUMS BEAUTE (FR) | 2020-10-15 | — | — | US | disclosed |
| EP-3463585-B1 | PERFUMES IN THE FORM OF AQUEOUS MICROEMULSIONS | CHANEL PARFUMS BEAUTE (FR) | 2020-07-08 | — | — | EP | disclosed |
| US-20200179247-A1 | PERFUMES IN THE FORM OF AQUEOUS MICROEMULSIONS | CHANEL PARFUMS BEAUTE (FR) | 2020-06-11 | — | — | US | disclosed |
| US-20200179247-A1 | PERFUMES IN THE FORM OF AQUEOUS MICROEMULSIONS | CHANEL PARFUMS BEAUTE (FR) | 2020-06-11 | — | — | US | disclosed |
| EP-3630057-A1 | PERFUMES IN THE FORM OF AQUEOUS MICROEMULSIONS | Chanel Parfums Beauté (FR) | 2020-04-08 | — | — | EP | disclosed |
| US-7074258-B2 | Process for dehydrating gas | BP EXPLORATION OPERATING COMPANY LIMITED (GB) | 2006-07-11 | — | — | US | disclosed |
| EP-1372824-B1 | PROCESS FOR DEHYDRATING GAS | BP EXPLORATION OPERATING (GB) | 2004-08-11 | — | — | EP | disclosed |
| US-20040139855-A1 | Process for dehydrating gas | BP EXPLORATION OPERATING COMPANY LIMITED (GB) | 2004-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200323749-A1 | PERFUMES IN THE FORM OF AQUEOUS MICROEMULSIONS | SGMS1, MGLL, FFAR1 | USP2 4503/4885LPAR1 123/4885LPAR3 255/4885 |
| US-20200179247-A1 | PERFUMES IN THE FORM OF AQUEOUS MICROEMULSIONS | MGLL, DSG1, ERG28 | USP2 2569/4885LPAR1 997/4885LPAR3 1296/4885 |
| US-11052025-B2 | Perfumes in the form of aqueous microemulsions | SGMS1, MGLL, FFAR1 | USP2 4503/4885LPAR1 123/4885LPAR3 255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.